phrykt

Bioventus Inc. (BVS): who owns it and who trades it

As of Nov 16, 2026, BVS insiders reported 2 open-market sales worth $181K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Michelle McMurry-Heath (Director), with $105K. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Bioventus

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Funds mostly bought. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns BVS

156 funds and institutions reported BVS shares worth $570M at the end of Q2 2026. The largest holder is Essex Woodlands Management, Inc. with $123M.

10 largest owners, by value

Essex Woodlands Management, Inc.$123M
Nantahala Capital Management, LLC$113M
Juniper Investment Company, LLC$65.5M
BlackRock, Inc.$32.4M
Royce & Associates LP$17.3M
Vanguard Capital Management LLC$16.5M
Geode Capital Management, LLC$12.9M
American Century Companies Inc$12.8M
Dimensional Fund Advisors LP$10.7M
State Street Corp$10.4M

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Essex Woodlands Management, Inc.13.02M–$123MNo change
Nantahala Capital Management, LLC12.00M–$113M+96%
Juniper Investment Company, LLC6.94M–$65.5MNo change
BlackRock, Inc.3.44M–$32.4M+10%
Royce & Associates LP1.83M–$17.3M+19%
Vanguard Capital Management LLC1.75M–$16.5M+2%
Geode Capital Management, LLC1.37M–$12.9M+17%
American Century Companies Inc1.35M–$12.8M+118%
Dimensional Fund Advisors LP1.13M–$10.7M+29%
State Street Corp1.10M–$10.4M+12%
Vanguard Portfolio Management LLC1.04M–$9.8M+7%
Hillsdale Investment Management Inc.907,739–$8.6M+35%
Engine Capital Management, LP900,558–$8.5M+186%
Wellington Management Group LLP748,358–$7.1M+386%
Renaissance Technologies LLC736,000–$6.9M+50%
Oberweis Asset Management Inc/709,714–$6.7M+13%
Goldman Sachs Group Inc652,367–$6.2M+38%
Kennedy Capital Management LLC466,563–$4.4M-2%
FMR LLC (Fidelity)452,850–$4.3M+14%
Northern Trust Corp443,824–$4.2M+22%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, BVS insiders reported $0 of open-market purchases and $181K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$181K
2 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Mar 11, 2026
Filed Mar 13, 2026

Purchases and sales by month

$105K$105KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Mar 11, 2026Michelle McMurry-HeathDirectorSale12,000$8.79$105KForm 4
Dec 4, 2025Guy P NohraDirectorSale10,000$7.57$75.7KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Michelle McMurry-HeathDirector–$105KMar 11, 2026
Guy P NohraDirector–$75.7KDec 4, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BVS short interest

3.02M BVS shares are sold short. Over the last 12 reports the number of shares short went up 92%.

As of Oct 30, 2026, 3.02M BVS shares were sold short, down 4.9% from the report before. At the average daily volume of 456,488 shares, buying them all back would take about 6.6 trading days (days to cover).

Shares short

3.02MMay 15Oct 303.42M

Days to cover

6.6May 15Oct 309.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.02M–-5%456,4886.6
Oct 15, 20263.18M–+1%355,2038.9
Sep 30, 20263.16M–+8%471,6366.7
Sep 15, 20262.93M–+14%511,2735.7
Aug 31, 20262.58M–+11%554,5414.7
Aug 14, 20262.33M–-8%1.01M2.3
Jul 31, 20262.54M–-7%653,5723.9
Jul 15, 20262.73M–+25%771,8093.5
Jun 30, 20262.18M–+13%672,5703.2
Jun 15, 20261.93M–+5%718,4172.7
May 29, 20261.84M–+17%728,1232.5
May 15, 20261.58M–+8%537,9362.9

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Bioventus company events

Bioventus filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 2, 2026.

  1. Nov 2, 2026ResultsReleased financial results. Filing
  2. Aug 5, 2026AnnouncementAs previously announced, following receipt of a recent unsolicited acquisition proposal from a party interested in acquiring the Company and multiple other expressions of interest, the Company’s Board of Directors established a committee of independent directors, which, with the assistance of… Filing
  3. Jun 4, 2026VoteReported shareholder vote results. Filing
  4. May 21, 2026AnnouncementShared information with investors. Filing
  5. May 6, 2026ResultsReleased financial results. Filing
  6. Mar 5, 2026ResultsReleased financial results. Filing
  7. Nov 17, 2025LeadershipThe Board of Directors of Bioventus Inc. appointed Ajay Dhankhar, PhD, to the Board as a Class II director effective on November 14, 2025. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Bioventus financials

Famous investors that hold BVS

2 of the 50 well-known investors we track reported holding BVS in their latest 13F filing. The largest position is Jim Simons's, worth $5.9M.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026432,136$5.9M0.0%-41%
Ken Griffin · Citadel AdvisorsQ3 202616,298$222K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named BVS in the last 120 days.

FiledHolderFormStake
Nov 13, 2026BROWN ADVISORY INC13G5.8%
Nov 13, 2026BROWN ADVISORY INC13G5.8%
Oct 27, 2026BlackRock, Inc.13G/A4.9%
Oct 27, 2026BlackRock, Inc.13G/A4.9%

Questions about Bioventus Inc. (BVS) stock

Who owns the most BVS stock?

The largest reported owner of Bioventus Inc. (BVS) is Essex Woodlands Management, Inc.. In total, 156 funds and institutions reported holding BVS at the end of Q2 2026. See the largest owners.

Are BVS insiders buying or selling?

In the last 12 months, BVS insiders reported no open-market purchases and 2 sales worth $181K. The latest trade was on Mar 11, 2026. See every trade.

What is the short interest in BVS?

As of Oct 30, 2026, 3.02M BVS shares were sold short, down 4.9% from the report before. At the average daily volume of 456,488 shares, buying them all back would take about 6.6 trading days (days to cover). See the history.

Which famous investors hold BVS?

2 of the 50 well-known investors we track reported BVS in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $5.9M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.